Home > Insider Trading > Filing (0001209191-21-032078)

Filing Details

Accession Number:: 0001209191-21-032078
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-12 13:00:00
Reporting Period:: 2021-05-10

Accepted Time:: 2021-05-12 16:51:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1662774	Cortexyme Inc.	CRTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1770783	Casey Lynch	C/O Cortexyme, Inc. 269 East Grand Ave. South San Francisco CA 94080	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-10	13,584	$33.75	995,190	No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock	Disposition	2021-05-10	9,918	$34.89	985,272	No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock	Disposition	2021-05-10	6,315	$35.81	978,957	No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Common Stock	Disposition	2021-05-10	183	$36.73	978,774	No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009
No	4	S	Indirect	By the Zachary and Casey Lynch Living Trust dated February 24, 2009

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	49,895	Direct
Common Stock	91,911	Indirect	By The Casey C. Lynch 2019 Annuity Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 29, 2020 and amended on December 18, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.41 to $34.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Casey C. Lynch is a trustee of the Zachary and Casey Lynch Living Trust dated February 24, 2009, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Zachary and Casey Lynch Living Trust dated February 24, 2009.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.41 to $35.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.44 to $36.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Casey C. Lynch is the trustee of The Casey C. Lynch 2019 Annuity Trust, and holds sole voting and dispositive power with respect to the shares held of record by The Casey C. Lynch 2019 Annuity Trust.